After decades of unfulfilled potential, the commercial reality of gene therapies is rapidly taking shape. However, the leading drug developer organizations in this field are telling us that developing effective analytical strategies is a major bottleneck for them, and that they have little visibility into which contract service providers and technology providers have the analytical experience and specific technologies to meet their demands.
Analytical and CMC leaders at the leading companies in the gene therapy field will unite this November at the Gene Therapy Analytical Development Summit, actively seeking to collaborate with organizations that can help them solve analytical challenges holding back progress to market.
If you have capabilities that would benefit our audience, Gene Therapy Analytical Development will provide a unique platform to showcase your solutions, generate new business leads and source opportunities for partnerships.
"First time we participated to this meeting. All the main players in Cell and Gene Therapy were gathered. Perfectly organized, good size to meet and network."
Previous Hanson Wade Gene Therapy Series Partner - Polyplus Transfection
Email us at email@example.com for more information about the partnership opportunities available which will deliver on your commercial objectives this year. Act now to stay ahead of the curve and seize the wealth of opportunity on offer.